Key result
Prompt reperfusion and adjunctive therapies reduce recurrent cardiovascular events in STEMI by minimizing ischemia.
Why the study?
Recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction needed to be summarized for clinicians.
This review summarizes the standard of care for STEMI, emphasizing prompt reperfusion and comprehensive adjunctive medical therapy.
Answers are grounded in this paper and cite their sources.
Prompt reperfusion remains essential in STEMI care; leaves open optimization of adjunctive regimens for trials.
OBJECTIVE: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction. DATA SOURCES: PubMed search and review of relevant medical literature. SUMMARY: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed. CONCLUSIONS: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Trost et al. (2012) conducted a review in ST-segment elevation myocardial infarction. Reperfusion therapy and adjunctive medical therapy was evaluated. Prompt reperfusion therapy and adjunctive medical treatments benefit patients with ST-segment elevation myocardial infarction by minimizing ischemia and reducing recurrent cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: